Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NeoPUTTY MTA
- Development stage
- Unknown
- Lead developer
- NuSmile
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Administration
- Intradental, Endodontic, Intracanal, Intrapulpal
01
Overview
NeoPUTTY MTA is a premixed, bioactive bioceramic mineral trioxide aggregate (MTA) material developed by NuSmile for use in pediatric and general dentistry. It is specifically designed for procedures such as pulpotomy, indirect pulp capping, and root repair. As a premixed putty, it eliminates the need for manual mixing of powder and liquid, ensuring a consistent consistency and improved handling characteristics compared to traditional MTA. The material is bioactive, triggering the formation of hydroxyapatite to promote healing and create a biological seal. It is highly radiopaque, non-staining, and sets in the presence of moisture, making it highly effective for applications involving pulp tissue and moist dental environments.
- Brand names
- NeoPUTTYNeoPUTTY MTA
- Other names
- Neo-puttypremixed bioactive bioceramic MTApremixed bioceramic MTA
Beyond the preview
Go deeper on NeoPUTTY MTA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NeoPUTTY MTA.